stage iii squamous cell carcinoma of the larynx

Showing 1 - 22 of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous

Recruiting
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • +50 more
  • transoral robotic surgery
  • quality of life assessment
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 28, 2022

Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell

Terminated
  • Stage III Squamous Cell Carcinoma of the Hypopharynx
  • +11 more
  • cetuximab
  • +3 more
  • Newark, New Jersey
    New Jersey Medical School
Apr 19, 2021

Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell

Terminated
  • Stage III Squamous Cell Carcinoma of the Hypopharynx
  • +11 more
  • erlotinib hydrochloride
  • +10 more
  • Cleveland, Ohio
    Case Medical Center, University Hospitals Seidman Cancer Center,
May 6, 2020

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage 0

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +57 more
  • placebo
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 18, 2020

Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the

Completed
  • Human Papilloma Virus Infection
  • +15 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Aug 10, 2018

Stage I Adenoid Cystic Carcinoma of the Oral Cavity, Stage I Mucoepidermoid Carcinoma of the Oral Cavity, Stage I Squamous Cell

Terminated
  • Stage I Adenoid Cystic Carcinoma of the Oral Cavity
  • +27 more
  • endoscopic procedure
  • questionnaire administration
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jun 29, 2018

Nausea and Vomiting, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx Trial

Terminated
  • Nausea and Vomiting
  • +10 more
  • fosaprepitant dimeglumine
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 13, 2017

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Terminated
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +45 more
  • talactoferrin
  • laboratory biomarker analysis
  • Stanford, California
    Stanford University
Jul 30, 2016

Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Lymphoepithelioma of the Nasopharynx, Recurrent

Terminated
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • +54 more
  • transoral robotic surgery
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Nov 7, 2014

Chemotherapeutic Agent Toxicity, Mucositis, Radiation Toxicity Trial in Buffalo, Hamilton (dietary supplement, other, drug,

Terminated
  • Chemotherapeutic Agent Toxicity
  • +15 more
  • selenomethionine
  • +4 more
  • Buffalo, New York
  • +1 more
Aug 8, 2014

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Stage III Squamous Cell Carcinoma of the

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +26 more
  • erlotinib hydrochloride
  • +5 more
  • Cleveland, Ohio
    Case Western Reserve University
Jun 5, 2014

Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Meningioma Trial in Houston (bevacizumab, , magnetic

Completed
  • Adult Anaplastic Astrocytoma
  • +86 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 21, 2014

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +38 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 2, 2014

Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the

Completed
  • Recurrent Salivary Gland Cancer
  • +21 more
  • erlotinib hydrochloride
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
Nov 21, 2013

Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell

Completed
  • Stage III Squamous Cell Carcinoma of the Hypopharynx
  • +9 more
  • erlotinib hydrochloride
  • +4 more
  • Anchorage, Alaska
  • +8 more
May 8, 2013

Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,

Completed
  • Advanced Adult Primary Liver Cancer
  • +126 more
  • recombinant interleukin-12
  • ABI-007/carboplatin/trastuzumab
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 27, 2013

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Adenoid Cystic Carcinoma of the Oral

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +53 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Feb 6, 2013

Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell

Terminated
  • Stage III Squamous Cell Carcinoma of the Hypopharynx
  • +7 more
  • Denver, Colorado
    University of Colorado
Jan 24, 2013

Anaplastic Thyroid Cancer, Insular Thyroid Cancer, Metastatic Parathyroid Cancer Trial in San Antonio (gefitinib)

Completed
  • Anaplastic Thyroid Cancer
  • +85 more
  • San Antonio, Texas
    Southwest Oncology Group
Jan 11, 2013

Recurrent NSCLC, Recurrent Ovarian Epithelial Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx Trial in Chicago

Completed
  • Recurrent Non-small Cell Lung Cancer
  • +29 more
  • erlotinib hydrochloride
  • +3 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jan 8, 2013